Differences among the DNA of seven ape species—including humans—are greater than originally thought, according to an ...

The genome database will open up the possibility of personalised medicine, and faster and efficient diagnostics. It will also ...

Their analyses revealed the green Sahara individuals likely branched off from the ancestors of sub-Saharan Africans roughly ...

Her expertise is in personal finance and investing, and real estate. Morsa Images / Getty Images Sequence risk is the danger that the timing of withdrawals from a retirement account will have a ...

According to three Stanford scientists, lack of human biological material is a “major bottleneck to progress” for medical research. A steadily growing idea is one known as “bodyoids ...

Until now, however, there has been no synthesis of the extent of human intervention in nature and whether the effects can be found everywhere in the world and in all groups of organisms.

Human “bodyoids” could reduce animal testing, improve drug development, and alleviate organ shortages. Why do we hear about medical breakthroughs in mice, but rarely see them translate into ...

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment ...

The addition of a candidate targeting glucagon, as well as GLP-1 and GIP, will add important optionality to our clinical pipeline, as we look to develop a broad portfolio of differentiated treatment ...

Novo Nordisk and the Chinese group’s wholly-owned subsidiary The United Bio-Technology have entered into an exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, ...